Notice Concerning Conclusion of Design-Build Contract for Okayama Second Factory
Filed with TSE · · 3 pages · English
Summary by 6ix AI
Fuso Pharmaceutical Industries, Ltd. has announced the conclusion of a design-build contract with Chiyoda X-ONE Engineering Corporation for the construction of the Okayama Second Factory, as part of its medium-term management plan. The new factory will enhance production efficiency and strengthen the company's supply capacity for essential pharmaceuticals.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/notice-concerning-conclusion-of-design-build-contract-for-okayama-second-factory
Fuso Pharmaceutical Industries,Ltd. on 6ix
Earlier from Fuso Pharmaceutical Industries,Ltd
- [Updated]Non-consolidated Financial Results for the Three Months Ended June 30, 2026[Under Japanese GAAP]
- TABLE-Fuso Pharmaceutical - 9-MTH parent results
- TABLE-Fuso Pharmaceutical - 6-MTH parent results
Later from Fuso Pharmaceutical Industries,Ltd
- Notice Concerning Revisions to Financial Result Forecasts for the Six Months Ended September 30, 2026
- Notice Concerning Appointment of Executive Officers and Organizational Changes
- Notice Concerning Revisions to Financial Result Forecasts and Dividend Forecasts for the Fiscal Year Ending March 31, 2027
- [Summary] Non-consolidated Financial Results for the Six Months Ended September 30, 2026 [Under Japanese GAAP]
- Supplementary Material on Financial Results for the Six Months Ended September 30,2026
Follow Fuso Pharmaceutical Industries,Ltd into a list and get an email when it puts out news.
Follow Fuso Pharmaceutical Industries,Ltd